We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bioinformatics Tool to Identify Chromosomal Alterations in Tumor Cells Can Improve Cancer Diagnosis

By LabMedica International staff writers
Posted on 25 Mar 2024
Print article
Image: Toroidal nuclei marked in magenta and micronuclei in green (Photo courtesy of IRB Barcelona)
Image: Toroidal nuclei marked in magenta and micronuclei in green (Photo courtesy of IRB Barcelona)

Chromosomal instability is a common characteristic in solid tumors, playing a crucial role in the start, progression, and spread of cancer. This condition arises from alterations in the chromosome number and structure during cell division, leading to DNA changes and impacts on cellular functions. Furthermore, chromosomal instability contributes to tumor development and progression, increases tumor diversity, and fosters resistance to cancer treatments. Now, a new bioinformatics tool that can identify these chromosomal alterations characteristic of cancer cells could improve diagnosis and help design personalized treatment plans.

This new detection system, known as QATS (QuAntification of Toroidal nuclei in biological imageS), has been designed by a research team from the University of Barcelona (Barcelona, Spain) and IRB Barcelona (Barcelona, Spain). This computational biological imaging processing tool can improve tumor research and classification by automatically identifying and quantifying the phenotypes associated with chromosomal instability in the nuclei of cancer cells. QATS focuses on detecting and quantifying toroidal nuclei, which are new biomarkers of chromosomal instability, in biological images. Unlike normal nuclei, toroidal nuclei are phenotypically different as they have a ring-like shape with a void containing cytosolic material. Recognized recently as critical biomarkers for chromosomal instability, toroidal nuclei offer a new avenue for understanding and combating cancer.

Until now, the assessment of chromosomal instability in cancer cells has been primarily based on quantifying micronuclei, which are irregular structures derived from the cell nucleus that may contain chromosomes or chromosomal fragments. By introducing the assessment of toroidal nuclei into both research and clinical settings, there is significant potential for improving tumor classification and developing treatments tailored to individual patients. The QATS system has already proven effective in preclinical studies involving cancer cell lines by demonstrating its capability to identify and quantify toroidal nuclei accurately.

“In the future, the application of QATS in more complex biological scenarios — human tissue samples from patient biopsies — will represent a breakthrough for the scientific and medical communities to improve cancer diagnosis and patient treatment”, concluded the researchers.

Related Links:
University of Barcelona
IRB Barcelona

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.